LEBLANC, CATHERINE,RITCHIE, CATHY,SHAW, DUNCAN,STIEFL, NIKOLAUS JOHANNES
申请号：
PL09738114
公开号：
PL2307402T3
申请日:
2009.04.27
申请国别(地区):
PL
年份:
2013
代理人:
摘要：
Compounds of formula (I): in free or salt or solvate form, where X, R1, R2, R3 and R4 have the meanings as indicated in the specification, are useful for treating diseases mediated by the ALK-5 and/or ALK-4 receptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
